Clinical trial
A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in…
NCT00418600 · Genzyme, a Sanofi Company, Industry · Completed
Key facts
| NCT number | NCT00418600 |
|---|---|
| Title | A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis |
| Official title | A Phase 4, Multi-Center, Open-Label, Randomized Study to Determine Clinically Appropriate Doses of Hectorol® Capsules When Converting From Hectorol® Injection for the Treatment of SHPT in Stage 5 CKD Subjects on Hemodialysis |
| Lead sponsor | Genzyme, a Sanofi Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Secondary Hyperparathyroidism |
| Intervention type | Drug |
| Interventions | Hectorol® (doxercalciferol capsules), doxercalciferol capsules, Hectorol®, Hectorol® capsules |
| Enrollment | 36 |
| Start date | Nov 1, 2006 |
| Primary completion | Jun 1, 2007 |
| Completion | Aug 1, 2007 |
| First posted | Jan 5, 2007 |
| Last update posted | Mar 19, 2015 |
| Countries | United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: